Source - LSE Regulatory
RNS Number : 6299V
Ilika plc
10 April 2019
 

Ilika plc

("Ilika" or the "Company")

 

Solid-state batteries enabling miniaturisation in MedTech

 

Ilika launches mm-scale batteries enabling new innovations in MedTech where size and safety are paramount

 

Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces the launch of Stereax® M50 mm-scale solid-state batteries designed for medical implants. The Stereax M50 takes solid-state batteries to a new level of miniaturisation enabling medical device innovations that have previously been limited by the available battery technology.

 

Mike Nagy, Chief Technology Officer of Endotronix, which develops Hemodynamic Monitoring Solutions where Ilika's technology could be applied,  said: "The implantable medical device industry has a growing need for miniaturised, long-life power sources to enable wireless data transfer from increasingly sophisticated devices that are improving patients' lives."

 

The 'MedTech' space is one of the most challenging environments for battery technologies. Batteries need to be small enough to be unobtrusive, enabling implantable devices to be charged in a way that does not restrict a patient, and have a long a life-span as possible, avoiding the risks associated with repeated surgical procedures. They also need to be biocompatible so that they do not pose a risk to the patient. Each device application may require different capacities and form factors, which can now be accommodated with the customisable battery sizes and shapes enabled by the Stereax M50. Innovation in applications that require injection into the blood stream, monitoring heart rhythm or attachment onto the peripheral nervous system for neurostimulation can be enabled with this technology. These batteries enable self-sustaining power sources that do not need to be changed regularly or use inconvenient cabling.

 

Relative to standard lithium ion batteries, Stereax M50 solid-state batteries have longer life spans of up to 10 years (up to 5x longer) and lower leakage currents (10x smaller), making them suitable for low power wireless charging. They can also be integrated with other electronic components enabling the end medical device to be kept as small as possible.  Stereax M50 yields leading edge energy density with 50% extra density compared to other commercially available solid-state batteries.

 

Graeme Purdy, CEO, Ilika said: "The Stereax product family continues to grow, addressing a wide range of end applications. Medical applications are some of the most demanding environments for battery technology. The Stereax M50 is a smaller, safer and longer lasting battery, opening up the opportunities of life enhancing medical devices."

 

For more information contact:

 

Ilika plc

 

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Liberum Capital Limited

Tel: 020 3100 2000

Andrew Godber, Cameron Duncan, Trystan Cullen, William Hall

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 / ilika@walbrookpr.com

Paul Cornelius

Mob: 07866 384 707

Lianne Cawthorne

Mob: 07584 391 303

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCCKCDDKBKDOQK
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.